Clearmind Medicine Inc.
|
(Name of Issuer)
|
common shares, no par value
|
(Title of Class of Securities)
|
185053402
|
(CUSIP Number)
|
December 31, 2023
|
(Date of Event Which Requires Filing of the Statement)
|
☒ |
Rule 13d-1(b)
|
☐ |
Rule 13d-1(c)
|
☐ |
Rule 13d-1(d)
|
Cusip No. 185053402
|
|
Page 2 of 5 Pages
|
1.
|
NAME OF REPORTING PERSONS
AdvisorShares Trust
|
||
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) ☐
(b) ☐
|
||
3.
|
SEC USE ONLY
|
||
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH
|
5.
|
SOLE VOTING POWER 92,693
|
|
6.
|
SHARED VOTING POWER 0
|
||
7.
|
SOLE DISPOSITIVE POWER 92,693
|
||
8.
|
SHARED DISPOSITIVE POWER 0
|
||
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 92,693
|
||
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
||
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.48%
|
||
12.
|
TYPE OF REPORTING PERSON (See Instructions) IV
|
||
Cusip No. 185053402
|
|
Page 3 of 5 Pages
|
Item 1(a). |
Name of Issuer: Clearmind Medicine Inc.
|
Item 1(b). |
Address of Issuer’s Principal Executive Offices:
|
Item 2(a). |
Name of Person Filing: AdvisorShares Trust
|
Item 2(b). |
Address of Principal Business Office or, if none, Residence:
|
Item 2(c). |
Citizenship: Delaware
|
Item 2(d). |
Title of Class of Securities: Common Shares, no par value
|
Item 2(e). |
CUSIP Number: 185053402
|
Item 3. |
If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
|
(a)
|
[ ]
|
Broker or dealer registered under Section 15 of the Act (15 U.S.C 78o);
|
|
(b)
|
[ ]
|
Bank as defined in Section 3(a)(6) of the Act (15 U.S.C 78c);
|
|
(c)
|
[ ]
|
Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C 78c);
|
|
(d)
|
[X]
|
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
|
(e)
|
[ ]
|
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
|
|
(f)
|
[ ]
|
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
|
(g)
|
[ ]
|
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
|
(h)
|
[ ]
|
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
(i)
|
[ ]
|
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
|
|
(j)
|
[ ]
|
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
|
|
(k)
|
[ ]
|
Group, in accordance with § 240.13d-1(b)(1)(ii)(K).
|
Cusip No. 185053402
|
|
Page 4 of 5 Pages
|
Item 4. |
Ownership:
|
Provide the following information regarding the aggregate number and percentage of class of securities of the issuer identified in Item 1.
|
(a)
|
Amount beneficially owned: 92,693
|
||
(b)
|
Percent of Class: 5.48%
|
||
(c)
|
Number of shares as to which such person has:
|
||
(i)
|
sole power to vote or to direct the vote: 92,693
|
||
(ii)
|
shared power to vote or to direct the vote: 0
|
||
(iii)
|
sole power to dispose or to direct the disposition of: 92,693
|
||
(iv)
|
shared power to dispose or to direct the disposition of: 0
|
Item 5. |
Ownership of Five Percent or Less of a Class:
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person:
|
Item 7. |
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
|
Item 8. |
Identification and Classification of Members of the Group:
|
Item 9. |
Notice of Dissolution of Group:
|
Cusip No. 185053402
|
|
Page 5 of 5 Pages
|
February 14, 2024
|
|
(Date) | |
/s/ Stefanie Little
|
|
(Signature)
|
|
Stefanie Little – Chief Compliance Officer
|
|
Name and Title |